Alzheimer s Disease Pilot Clinical Trials (R01)
The summary for the Alzheimer s Disease Pilot Clinical Trials (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Alzheimer s Disease Pilot Clinical Trials (R01): -In 1999, at the direction of Congress, the National Institute on Aging (NIA), in conjunction with the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Mental Health (NIMH), and the National Institute of Nursing Research (NINR) embarked on the Alzheimer's Disease (AD) Prevention Initiative, which encompasses a number of interrelated efforts including basic, epidemiological, behavioral, and clinical research. An important part of the AD Prevention Initiative is to quicken the pace for translating basic science findings into clinical trials to evaluate treatment and prevention strategies. This funding opportunity announcement (FOA) focuses on AD pilot clinical trials while other FOAs are targeted to AD drug discovery and development. -In this FOA the National Institute on Aging (NIA), the National Center for Complementary and Alternative Medicine (NCCAM), and the National Institute of Nursing research (NINR) invite qualified investigators to submit research grant applications for pilot clinical trials using pharmacologic and/or behavioral interventions directed toward the prevention and treatment of the cognitive and behavioral symptoms of mild cognitive impairment (MCI), Alzheimer's disease (AD), and age-related cognitive decline.
| Federal Grant Title: | Alzheimer s Disease Pilot Clinical Trials (R01) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Education Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PAR-08-062 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.21393.361 |
| CFDA Descriptions: | Research and Training in Complementary and Alternative Medicine 93.361 Nursing Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Jan 07, 2011 |
| Posted Date: | Dec 27, 2007 |
| Creation Date: | Dec 27, 2007 |
| Archive Date: | Dec 05, 2008 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | 93.866 -- Aging Research |
- Applicants Eligible for this Grant
- Small businesses Native American tribal governments (Federally recognized) Special district governments Private institutions of higher education Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) City or township governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster